Lapatinib-Binding Protein Kinases in the African Trypanosome: Identification of Cellular Targets for Kinase-Directed Chemical Scaffolds

Katiyar, Samiksha; Kufareva, Irina; Behera, Ranjan; Thomas, Sarah M.; Ogata, Yuko; Pollastri, Michael; Abagyan, Ruben; Mensa-Wilmot, Kojo
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Human African trypanosomiasis is caused by the eukaryotic microbe Trypanosoma brucei. To discover new drugs against the disease, one may use drugs in the clinic for other indications whose chemical scaffolds can be optimized via a medicinal chemistry campaign to achieve greater potency against the trypanosome. Towards this goal, we tested inhibitors of human EGFR and/or VEGFR as possible anti-trypanosome compounds. The 4-anilinoquinazolines canertinib and lapatinib, and the pyrrolopyrimidine AEE788 killed bloodstream T. brucei in vitro with GI50 in the low micromolar range. Curiously, the genome of T. brucei does not encode EGFR or VEGFR, indicating that the drugs recognize alternate proteins. To discover these novel targets, a trypanosome lysate was adsorbed to an ATP-sepharose matrix and washed with a high salt solution followed by nicotinamide adenine dinucleotide (NAD+). Proteins that remained bound to the column were eluted with drugs, and identified by mass spectrometry/bioinformatics. Lapatinib bound to Tb927.4.5180 (termed T. brucei lapatinib-binding protein kinase-1 (TbLBPK1)) while AEE788 bound Tb927.5.800 (TbLBPK2). When the NAD+ wash was omitted from the protocol, AEE788, canertinib and lapatinib eluted TbLBPK1, TbLBPK2, and Tb927.3.1570 (TbLBPK3). In addition, both canertinib and lapatinib eluted Tb10.60.3140 (TbLBPK4), whereas only canertinib desorbed Tb10.61.1880 (TbCBPK1). Lapatinib binds to a unique conformation of protein kinases. To gain insight into the structural basis for lapatinib interaction with TbLBPKs, we constructed three-dimensional models of lapatinib•TbLBPK complexes, which confirmed that TbLBPKs can adopt lapatinib-compatible conformations. Further, lapatinib, AEE788, and canertinib were docked to TbLBPKs with favorable scores. Our studies (a) present novel targets of kinase-directed drugs in the trypanosome, and (b) offer the 4-anilinoquinazoline and pyrrolopyrimidines as scaffolds worthy of medicinal chemistry and structural biology campaigns to develop them into anti-trypanosome drugs.


Related Articles

  • Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency? Hasker, Epco; Lutumba, Pascal; Chappuis, François; Kande, Victor; Potet, Julien; De Weggheleire, Anja; Kambo, Charles; Depoortere, Evelyn; Pécoul, Bernard; Boelaert, Marleen // PLoS Neglected Tropical Diseases;Dec2012, Vol. 6 Issue 12, p1 

    The author discusses the prevalence of Human African Trypanosomiasis (HAT) in the Democratic Republic of Congo (DRC). The author states that HAT is also known as sleeping sickness which is a parasitic disease which is fatal if left untreated. He notes that DRC is the worst affect country of HAT....

  • On the extent and role of the small proteome in the parasitic eukaryote Trypanosoma brucei. Ericson, Megan; Janes, Michael A.; Butter, Falk; Mann, Matthias; Ullu, Elisabetta; Tschudi, Christian // BMC Biology;2014, Vol. 12 Issue 1, p1 

    Background Although technical advances in genomics and proteomics research have yielded a better understanding of the coding capacity of a genome, one major challenge remaining is the identification of all expressed proteins, especially those less than 100 amino acids in length. Such information...

  • Ab Initio Identification of Novel Regulatory Elements in the Genome of Trypanosoma brucei by Bayesian Inference on Sequence Segmentation. Kelly, Steven; Wickstead, Bill; Maini, Philip K.; Gull, Keith // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Background: The rapid increase in the availability of genome information has created considerable demand for both comparative and ab initio predictive bioinformatic analyses. The biology laid bare in the genomes of many organisms is often novel, presenting new challenges for bioinformatic...

  • Overview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years? Bonnet, Julien; Boudot, Clotilde; Courtioux, Bertrand // BioMed Research International;10/4/2015, Vol. 2015, p1 

    Sleeping sickness is a parasitic infection caused by two species of trypanosomes (Trypanosoma brucei gambiense and rhodesiense), transmitted by the tsetse fly. The disease eventually affects the central nervous system, resulting in severe neurological symptoms. Without treatment, death is...

  • The trypanolytic factor of human serum. Pays, Etienne; Vanhollebeke, Benoit; Vanhamme, Luc; Paturiaux-Hanocq, Françoise; Nolan, Derek P.; Pérez-Morga, David // Nature Reviews Microbiology;Jun2006, Vol. 4 Issue 6, p477 

    African trypanosomes (the prototype of which is Trypanosoma brucei brucei) are protozoan parasites that infect a wide range of mammals. Human blood, unlike the blood of other mammals, has efficient trypanolytic activity, and this needs to be counteracted by these parasites. Resistance to this...

  • Trypanocidal activity of the proteasome inhibitor and anti-cancer drug bortezomib.  // Parasites & Vectors;2009, Vol. 2 Issue 1, p29 

    The article presents a report on the in vitro activity of the proteasome inhibitor and anti-cancer drug bortezomib against bloodstream forms of Trypanosoma brucei. To reduce the growth rate by 50% and to kill all trypanosomes were 3.3 nM and 10 nM, respectively, it requires the concentrations of...

  • Gambiense sleeping sickness: re-emerging and soon untreatable? Van Nieuwenhove, Simon // Bulletin of the World Health Organization;2000, Vol. 78 Issue 11, p1283 

    Editorial. Comments on the return of sleeping sickness caused by Trypanosoma brucei gambiense. Deterioration and disruption of control activities; Problems on the implementation of active case detection and successful treatment; Gap between scientific progress and the implementation of...

  • Apolipoprotein L-I is the trypanosome lytic factor of human serum. Vanhamme, Luc; Paturiaux-Hanocq, Francoise; Poelvoorde, Philippe; Nolan, Derek P.; Lins, Laurence; Van Den Abbeele, Jan; Pays, Annette; Tebabi, Patricia; Van Xong, Huang; Jacquet, Alain; Moguilevsky, Nicole; Dieu, Marc; Kane, John P.; De Baetselier, Patrick; Brasseur, Robert; Pays, Etienne // Nature;3/6/2003, Vol. 422 Issue 6927, p83 

    Human sleeping sickness in east Africa is caused by the parasite Trypanosoma brucei rhodesiense. The basis of this pathology is the resistance of these parasites to lysis by normal human serum (NHS). Resistance to NHS is conferred by a gene that encodes a truncated form of the variant surface...

  • The Kinetoplastid Chemotherapy Revisited: Current Drugs, Recent Advances and Future Perspectives. Castillo, E.; Dea-Ayuela, M. A.; Rangel, M.; Bolás-Fernández, F.; González-Rosende, M. E. // Current Medicinal Chemistry;Nov2010, Vol. 17 Issue 33, p4027 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics